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Ob, ectiws. This study was undertaken to determine whether
early successful thrombolysis can reverse Infarct-associated mitral
valve dysfunction.
ffac und. Mitral regurgitation is a common complication of
acute my infarction and has been shown to adversely
affect both short- and long-term prognosis . Although anecdotal
reports have suggested that reperfusion of the infarct-related
artery may restore normal function to the mitral valve, this theory
has not been subjected to formal investigation .
Methods. Patients with total or partial obstruction of the
infarct-related artery received intravenous thrombolytic therapy
with either streptokinase or recombinant tissue-type plasminogen
activator within 7 h of symptom onset (mean 4.8 h) as part of the
Thrombolysis in Myocardial Infarction (TIMI) Phase I trial .
Repeat coronary an phy assessed arterial patency at 90 min
and 10 days after attempted repertusion. The presence and
severity of mitral regurgitation were determined by contrast
venulc phy both before thrombolysis and before hospital
disco
Results. Overall, 21(16 0) of the 1ѣ2 study patients exhibited
mitral regurgitation on either their initial or their p isch e
One important sequela of acute myocardial infarction is
persistent dysfunction of the mitral valve . This complication
not only can lead to early sudden death (1) but also has been
shown to have a major impact on 1-year mortality (2,ѣ) . The
past decade has witnessed tremendous growth in the under-
standing of the mechanisms underlying acute infarction,
accompanied by the development of chemical and mechan-
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ventriculogram. The proportion of infarct-related arteries found
to be patent (TIMI flow grade 2 or ѣ) was statistically similar in
patients with and without mitral regurgitation during each anglo-
graphic evaluation period (initial, 90 min and 10 days) . Although
coronary artery
perfusion
increased overall during sequential
measurement (mean TIMI grade was 0.4 ± 0 .6 initially, 1 .5 ± 1 .ѣ
at 90 min and 2.2 ± 1 .0 t 10 days), the pattern of reperfusion
observed could not predict an increase or decrease in regurgitant
severity (p = NS) . Early mitral regurgitation resolved in 57% of
patients by 10 days, but this resolution appeared independent of
the presence or absence of improved coronary perfusion (60% vs .
600). The development of new regurgitation during the recovery
period (6%) was also unrelated to improved perfusion (7% vs .
4%).
Conclusions. Acute mitral regurgitation developing during
myocardial infarction shows frequent changes in its presence or
severity during the 1st 10 days, appears independent of coronary
artery potency both early and late after thrombolysis and cannot
he reliably treated by improving arterial perfusion with thrombo-
lytic agents .
(J Am Cog Carw'iol 199ѣ,22:714-9)
ical techniques designed to abort the process and lessen the
extent of necrosis . It is possible that the same processes that
lead to myocardial salvage during reperfusion may limit or
reverse mitral valve incompetence . Indeed, several case
reports have been published that appear to support this
theory (4-6); however, more controlled trials have not been
reported to date .
The current study examines this hypothesis as part of the
Thrombolysis in Myocardial Infarction (TIMI) trial, using
the reference standard of contrast left ventriculography for
detection and quantitation of mitral regurgitation . Both the
patency and perfusion of the infarct-related artery and the
presence and severity of regurgitation were measured
shortly after presentation and before hospital discharge .
These variables were also compared in patients lacking
mitral regurgitation who served as a control group . The
relation of valvular function to vessel patency over time was
evaluated using several different analytic approaches .
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Methods
Study population . Patients enrolled in this study were
selected from participants in Phase I of the flMI trial, a
multicenter investigation sponsored by the National Heart,
Lung, and Blood Institute designed to establish the relative
throinbolyfic efficacy of intravenous streptokinase and re-
combinant tissue-type plasminogen activator (rt-PA) during
acute myocardial infarction (7) . Pretreatment coronary an-
giography and contrast left ventriculography in the acute
phase of infarction were standard requirements of this trial .
TIMI eligibility criteria included 1) age <76 years ; 2) severe
ischemic pain of at least ѣ0-min duration ; ѣ) new or presum-
ably new ?O.1 mV ST segment elevation in two or more
electrocardiographic leads ; 4) time interval <7 h between the
onset of symptoms and administration of thrombolytic ther-
apy; 5) lack of cardiogenic shock, uncontrolled hypertension
or left bundle branch block at presentation ; 6) ability and
willingness to grant informed consent . Three additional
criteria were required for entry into the current study : 7) lack
of previous myocardial infarction, cardiac surgery or dilated
cardiomyopathy to help exclude preexistent mitral regurgi-
tation; 8) good contrast ventriculograms free of artifactual
regurgitation arising from catheter malpositioning or ventric-
ular ectopic activity ; 9) repeat coronary angiography and
ventriculography before hospital discharge. The latter crite-
rion (predischarge catheterization) was requested of all
participants in the TIMI I trial and was performed in 64% of
the 206 patients who were otherwise eligible for inclusion in
the current study . The 1ѣ2 patients who satisfied all of the
aforementioned requirements form the basis of this report .
Protocol. Each patient was taken to the cardiac catheter-
izatiou laboratory shortly after presentation, where left
ventri .-ulography was performed in a ѣ0° right anterior
oblique position. Coronary arteriography was subsequently
undertaken, with the infarct-related artery carefully visual-
ized in orthogonal views both before and after administration
of intracoronary nitroglycerin . All patients with persistent
stenoses in the infarct-related artery of >50% diameter
reduction underwent randomization to receive either a 1-h
infusion of streptokinase (1 .5 million U) or a ѣ-h infusion of
rt-PA (80 mg). Repeat coronary injections were performed
90 min after initiation of thrombolytic therapy. Intravenous
administrr .on of heparin was started and was continued
until predischarge catheterization 8 to 10 days later (7) .
Quantitative analysis . All cineangiographic films were
sent to the Radiographic Core Laboratory at the University
of Washington, Seattle, for quantitative analysis . Antero-
grade coronary perfusion was assessed in the infarct-related
artery at baseline ("initial"), after 90 min of thrombolytic
therapy ("90 min") and before hospital discharge ("10
days") . Variables based on contrast left ventriculographic
analysis were measured before attempted thrombolysis
("early") and before hospital discharge ("late"). The extent
of perfusion was measured using the TIMI grading system :
grade 0 = no perfusion ; grade I = penetration without
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perfusion ; grade 2 = partial perfusion ; grade ѣ = full pertusion .
Endocardial contours were digitized from the left venticulo-
gram by an experienced observer at end-systole and end-
diastole using frames of minimal and maximal area, respec-
tively . Ventricular volumes were computed by the area-length
method after compensation for magnification and pincushion
distortion (8,9). The extent of akinesia/dyskinesia was deter-
mmea
I
using the centerline method and was expressed as a
percent of the left ventricular contour. Using a sinus beat,
mitral regurgitation was graded as "none" ff no contrast
medium appeared in the left atrium during ventricular injection,
"mild" if contrast medium did appear but was of insufficient
quantity to completely fill the left atrium and "moderate or
severe" if complete atrial opacification occurred . All analyses
were performed by observers unaware of the clinical variables .
Data analysis . Average data are expressed as mean val-
ues ± SD. Statistical analysis was performed using a two-
tailed unpaired t test and analysis of variance for continuous
variables where appropriate . Categoric variables were ana-
lyzed using a chi-square test for 2 x 2 contingency tables and
an exact test fm 2 x ѣ tables (10) ; p < 0.05 was required for
statistical significance .
ASKS
Of the 1ѣ2 patients enrolled in the study, 16% had mitral
regurgitation evident on either their initial or their predis-
charge contrast ventriculogram . The clinical, hemodynamic
and angiographic findings in these 21 patients are shown in
Table 1 . These variables were compared with those in
patients lacking mitral regurgitation (Table 2). A greater
proportion of patients exhibiting regurgitation were women
(p < 0.001), with a higher likelihood of involvement of the
left anterior descending coronary artery as the infarct-
related artery (p < 0 .05) ; however, other variables related to
ventricular size, function and filling, as well as enzymatic
index of the extent of myocardial necrosis, did not differ
significantly between groups .
The temporal pattern of vessel patency (TIMI perfusion
grade 2:2) for the infarct-related artery is graphically de-
picted in Figure 1, grouped into patients exhibiting initial
regurgitation on either ventriculogram (n = 21) and patients
with no ventriculographic evidence of regurgitation at any
time (n =- 111) . Before administration of thrombolytic ther-
apy, there was a statistically insignificant trend toward
higher arterial patency in patients lacking mitral regurgita-
tion ; however, after attempted thrombolysis, even this insig-
nificant trend disappeared, so that the patency rate did not
differ between the two groups at 10 days (76% vs . 68%, p
NS) .
Further analysis was undertaken to determine whether a
change in severity of mitral regurgitation over time was
accompanied by a change in perfusion in the infarct-related
artery . Figure 2 displays the mean vessel perfusion score in
the 16 patients in whom the severity of regurgitation either
improved (n = 8) or worsened (n = 8) over the 1st 10 days
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Table 1 . Clinical, Hemodynamic and Angiographic
Characteristics of the 21 Patients With Mitral Regurgitation *
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after infarction . Although on average, perfusion did improve
with time (overall mean TIMI grade was 0 .4 ± 0.6 initially,
l .5 ± 1.ѣ at 90 min and 2 .2 ± I,0 at 10 days), it did so to a
similar extent in each group, so that mean perfusion grades
did not differ significantly between groups at any given point
in time . Similarly, temporal changes in left ventricular per-
formance, assessed by ejection fraction, end-diastolic vol-
ume or extent of akinesialdyskinesia, could not predict
changes in regurgitation severity .
Finally, patients were separated according to whether or
not thrombolytic therapy produced an improvement in arte-
rial perfusion at 10 days (TIMI grade a :2) relative to the
initial angiogram. As shown in Figure ѣ (top), in approxi-
mately half of patients with initial mitral regurgitation, the
regurgitation resolved before the final ventriculographic
study; however, this rate of resolution was similar in those
with or without improved coronary perfusion (60% vs . 50%).
Similarly, the likelihood of developing mitral regurgitation in
patients with a competent valve initially (Fig . ѣ, bottom) was
independent of improvement in perfusion (7% vs . 4%) .
Discussion
It is widely recognized that mitral regurgitation can
develop during the course of acute myocardial infarction
*Clinical and catheterization data for all patients with mitral regurgitation on either ventriculogram. Dyskinesia = percent of chords that are akinetic or
dyskinetic ; Early - within 7 h of symptom onset ; EF = ejection fraction ; F = female : LAD = left anterior descending coronary artery ; Late = approximately
10 days after infarction ; LCx = left circumflex coronary artery ; LVEDP = left ventricular end-diastolic pressure ; LVEDV = left ventricularead-diastolic volume ;
M = male ; Max CK = maximal serum creatine kinase value ; Mod/sev m moderate or severe ; TIMI Perfusion = Thrombolysis in Myocardial Infarction perfusion
grade (baseline [0 min], after 90 min of thrombolytic therapy 190 min] and before hospital discharge [ 10 days]) ; Pt = patient ; RCA = right coronary artery ; rt-PA
intravenous recombinant tissue-type plasminogen activator ; SK -- intravenous streptokinase .
(11) . The previously published frequency of this complica-
tion varies with the techniques used for detection but ranges
from 10% to 55% (2,11-14) . W-a recently reported a 1ѣ%
prevalence of mitral regurgitation within the 1st 7 h of
symptom onset (ѣ) . In our series, this valvular lesion was
more common in patients with anterior infarction, but it did
not correlate with peak creatiae kinase levels or early
ventricular dilation . Moreover, the early presence of mitral
regurgitation was the strongest predictor of cardiovascular
mortality, with relative risks of 7 .ѣ at 10 days (95% confi-
dence interval [CI] 1 .4 to ѣ8 .4) and 12 .2 at I year (95% CI ѣ .5
to 42.0) . It is logical to hope that timely restoration of
valvular competence may improve this otherwise poor prog-
nosis .
Optimal restoration of valvular function requires an un-
derstanding of the underlying pathogenesis . Unfortunately,
the mechanisms involved in this complication appear to be
multifactorial . At one extreme is frank papillary muscle
rupture, leading to immediate hemodynamic compromise
and, often, to a quick demise (1) . At the other is a more
subtle disruption of the complex architecture that comprises
the valve and its supporting subvalvular apparatus (15).
Further controversy exists as to whether mitral valve incom-
petence is largely a problem of restricted papillary muscle
and leaflet motion, leading to incomplete valve closure, or to
Pt
No.
Age WY
Gender
Mitral
Regurgitation
Infarct-
TIMI Perfusion
EF
LVEDV
(ml)
LVEDP
(mm Hg)
Dyskinesia
(%)
Related 0 90 10 Max CK Thrombolytic
Early Late
Early
Late
Early
Late
-
Early Late 0=0 AgentArtery min min days Early Late
I WM Mild Mild RCA 0 ѣ ѣ
ѣ8 ѣѣ 221 240 8 10 20 11 1,410 rt-PA
2 591M Mild Mild LAD 1 0 1 41 41 121 16ѣ 25 10
ѣ6 ѣ7 4,080 SK
ѣ 591F Mild Mild LAD 2 2 2 51 59 97 102 20 10 27 18 1,ѣ96 SK
4 71/F Mild Mild LAD 0 0 ѣ 55 61
105 72 ѣ6 ѣ0 22 5 5,000 SK
5 651M Mild Mild LAD 1 2 ѣ ѣ8 46 102 107 20 24 19 12 4,6ѣ0 rt-PA
6 61/F Mild Modlsev RCA 0 ѣ ѣ 51 61 99 106
18 18 0 0 1,990 rt-PA
7 74/F Mild None LAD I ѣ ѣ ѣ7 ѣ9 98 106 ѣ5 18 ѣ7 24 2,8ѣ5 rl-PA
8 70/M Mild None LAD 0 1 ѣ 5ѣ 50 169 18ѣ 20 14 18 10 1,705 SK
9 411M Mild None LAD 0 0 I 54 59 144 1ѣ1 20 10 1ѣ 12 2,1ѣ6 rt-PA
10 67/F Mild None RCA 0 0 2 56
54 75 98 12 14 0 4
892 SK
11 55/M Mild None LAI)
I ѣ ѣ ѣ9 28 227 179 15 8 15 21 1,978 rt-PA
12 60/M Mild None LAD 0 2 ѣ ѣ9 ѣ9 161 181 ѣ4 16 40 ѣ6 ѣ,55ѣ SK
1ѣ ѣ6/M Mild None RCA 0 1 0 42 ѣ8 17ѣ 116 22 16 1 0 1,596 SK
14 68/F Mod/sev None RCA 0 1 ѣ 46 55 1ѣ2 1ѣѣ 12 6 8 5 52ѣ Ft-PA
15 51/17 None Mild LAD I
ѣ ѣ ѣ8 45 10ѣ 89 26 is
ѣ7
25 ѣ,468
rt-PA
16 ѣѣ/M None
Mild RCA 0 0 2 58 42 17ѣ 197 16 20 0 14 7 .744 SK
17 641M None Mild LAD 0 0
ѣ 46 ѣѣ 1ѣ7 1ѣ1
25
27 ѣѣ ѣ2 1,206 SK
18 66/M None Mild RCA 0 0 0 62 58 140 1ѣѣ 6 15 6 541 SK
19 55/M None Mild RCA 0 1 1 71 64 108 87 14 14 0 ѣ 606 SK
Zo ѣ71M None Mild LCx 0 ѣ ѣ 51 49 127 1ѣ2 20 14 0 0 4 .770 rt-PA
21 74/F None Mod/sev RCA I ѣ 2 49 56 62 89 ѣ0 20 2 0 2,615 rt-PA
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Table 2.  Comparison of Patients With and Without
Mitral Regurgitation
*p < 0.001 . tp < 0 .05 . Values presented are mean values ± SD unless
otherwise indicated
. Abbreviations as in Table 1
.
exaggerated leaflet movement beyond the line of closure,
producing valve prolap~e (15) .
The classic interventional approach to mitral valve dys-
function in this setting has been surgical replacement or
repair, usually in conjunction with coronary artery bypass
procedures. Uncontrolled series have suggested a survival
benefit over that of medical treatment alone (4,16-18),
although perioperative mortality can range up to 41% (4) .
Because of this high surgical risk, an effective alternative
approach to restoring valve competency would clearly be
preferable .
In theory, reestablishing perfusion in the infarct-related
artery early in the course of an evolving myocardial infarc-
tion might restore the functional integrity of the mitral valve
without surgery . Several investigators have reported anec-
dotal evidence that supports this concept . Shawl et al . (5)
were apparently able to reverse moderate and severe acute
mitral regurgitation in five patients undergoing emergency
coronary angioplasty during infarction, as evidenced by a
significant improvement in pulmonary capillary wedge pres-
sure after reperfusion . Follow-up contrast ventriculography
at a mean of ѣ5 months revealed no mitral regurgitation in
three of four patients tested (5) . This same technique was
100%
0%-
2.5
2&
1
1 .0
0 .5 1
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Any PAR
No MR
Initial
At 90 min At 10 days
TIMING OF CORONARY ANGIOGRAM
Figure 1 . Infarct-related artery patency over time subgrouped by
the presence or absence of angiographic mitral regurgitation (MR) .
Patients are grouped according to those with regurgitation observed
on their early or late ventriculogram (any MR) and those without
regurgitation evident on either study (no MR) . All differences were
statistically nonsignificant . L-TIMI 2 = Thrombolysis in Myocardial
Infarction flow grade 2 or greater .
successfully applied by Heuser et al . (6) to three patients
with severe regurgitation . two of whom were in cardiogenic
shock at the time of the procedure . The mean pulmonary
wedge pressure decreased from ѣ4 to 10 mm Hg after
successful coronary dilation in these three patients, with no
clinical heart failure or auscultatory evidence of mitral
regurgitation observed at 1-year follow-up. Recently,
Hickey et al. (4) retrospectively reported or, nine patients
undergoing angioplasty within 24 h of the onset of infarction .
Six of the nine patients experienced complete resolution of
regurgitation after successful reperfusion .
The favorable results noted in these uncontrolled reports
are not reflected in our data . Although a different technique
was used in our study to establish reperfusion (intravenous
Figure 2. Average Thrombolysis in Myocardial Infarction (TIMI)
perfusion grade of infarct-related artery over time in the 16 patients
with mitral regurgitation (MR) that either decreased (improved MR)
or increased (worsened MR) in severity from the early to the late
ventriculogram. Error bars denote standard error .
IJU
ѣ .0 1
0
4
1 M Improved MR
cc
0
z
2
U)
IL
>-
X
1 .5
0
z
~ 0 .0 1-
Initial at 90 min
al 10 days
TIMING OF CORONARY ANGIOGRAM
Mitral Regurgitation
Present
(n=21)
Absent
In = 1H)
Age (y
r) 58 ± 12 55 ± 10
Men (%) 62
90*
Infarct-related artery (0/v)f
RCA 4ѣ
50
LAD
52 40
LCx 5 10
Perfusion
0 6n 0,4 t 0A 0 .6 t 0 .9
90 min 1.5±1 .ѣ L1 .7= 1 .2
10 day 2 .2 t 1 .0 2 .0 t 1 .ѣ
EF (%)
Early 48ѣ t 9 .2 50 .2 t 9 .4
Late 48 .1 ± 10.7 51 .4 ± 9 .ѣ
LVEDV (ni1)
Early 1ѣ2 ± 4ѣ 145 it ѣ8
Late 1ѣ2 4ѣ 151 41
LVEDP (Iurn Hg)
Early
20.7 8 .4 t 9 .I 1- 10 .1
Late 15 .8 -!- 6 .1 15,0±6 .0
Extent of akinesia/dysitinesia (%)
Early 15.9 14.5 11 .ѣ 12 .8
Late 1ѣ.5 12.2 8 .9 11 .7
Max CK (IUlhter) 2,604 1,844 2 .ѣѣ0 1,665
Thrombolytic agent
SK 48 57
rt-PA 52 4ѣ
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NO
EARLY
MR
1 4/10
Z/4
1 500
2/46
IM Improved perfusion
Eѣ no Improved perfusion
EARLY
MR
0% 20% 40%
60%
80% 100%
PATIENTS WITH LATE MR
Figure
ѣ. Prevalence of late mitral regurgitation (MR)
in patients
with or without early regurgitation, based on whether coronary
flow
improved in the infarct-related artery between the baseline
and the
10 day coronary angiogram . Ratios (to the right of each
bar)
represent the number of patients with
late regurgitation in the
numerator, with the total number of patients in each group in the
denominator.
thrombolytic therapy vs . coronary angioplasty), the time to
achieving vessel patency was similar . The severity of regur-
gitation, however, was typically less in our study group . Our
results show no statistical difference in vessel patency after
thrombolysis in patients with or without mitral regurgitation .
In addition, vessel patency could not predict progression or
regression of the severity of valve dysfunction over the 1st
10 days after infarction. Similar results were obtained when
coronary perfusion grade was used as a nondichotomous and
potentially more physiologic marker of reperfusion . Im-
proved coronary perfusion after attempted thrombolysis did
not affect the frequency of late mitral regurgitation. Finally,
our data documented spontaneous resolution of mitral dys-
function in 57% of patients, with no apparent relation to
reperfusion. This phenomenon has not been addressed in
previous reports .
Study UmItations . Several potential limitations of our
study should be noted. Most important, although the current
study reports the largest experience to date, the total number
of patients included is small . Second, thrombolytic therapy
was initiated a mean of 4 .8 h after symptom onset ; earlier
treatment could possibly alter the results obtained . Third, of
all 206 TIMI I patients who represented potential candidates
for this study on their initial hospital day (ѣ), 74 (ѣ676) were
ultimately excluded because they did not receive an ade-
quate repeat contrast ventriculogram before discharge .
When considering only the 27 patients with initial mitral
regurgitation, the proportion excluded was even higher
(48%). Stated reasons given for exclusion in the latter
subgroup consisted of in-hospital death in three, patient
refusal in two, physician refusal in two and technical/logistic
difficulties in six . Therefore, caution is advised in the gener-
alized application of our findings to patients who do not
JACC Vol . 22, No. ѣ
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exactly match this select group of patients with acute infarc-
tion . The fourth limitation relates to the 10--day time period
between attempted thrombolysis and reassessment of mitral
valve function. It is possible that some of the vessels
documented as patent on the late angiogram may have had
reperfusion after the critical period needed for myocardial
preservation . Alternative;!y , the 10-day delay before reas-
sessment may have been eoo short to allow total recovery of
residual myocardial function after infarction .
Conclusions . Despite these limitations, the findings from
this study support several conclusions . 1) Mitral regurgita-
tion is a common complication of acute myocardial infarc-
tion, with frequent changes in its presence and severity
during the 1st 10 days after infarction . 2) Vessel patency both
early and late after attempted thrombolysis appears similar
in patients with and without mitral regurgitation . ѣ) Neither
progression nor regression of mitral regurgitation appears to
be influenced by changes in perfusion in the infarct-related
artery . We hope that other approaches can be devised in the
future to favorably influence the ominous natural history of
infarct-associated mitra .1 valve dysfunction .
We are indebted to Victor Froelicher, MD and Nathan Wong, PhD for their
editorial review, to the Maryland Medical Research Institute for assistance in
data analysis and to Julie Werton for manuscript preparation
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